Side Effects of topical drugs due to prolonged application still remains a key restraint in the development of the market. How can drug delivery companies get around this problem? Find out today.
Owing to the COVID-19 pandemic, the supply chain and demand of topical drug delivery has been affected in 2020. But it is not just COVID-19 that affects the future of topical drug delivery. This unique senior report tells you what direction the market will take – and it tells you today.
Discover how to stay ahead
Our 600+ page report provides 600+ tables, charts, and graphs.
By reading this report you will discover the most lucrative areas in the industry and the future market prospects. Our study lets you assess forecasted sales at overall world market, regional and country specific level. See financial performance of companies, trends, opportunities, and revenue growth. Much opportunity remains in this growing Topical drug delivery Market. See how you can exploit these opportunities.
UNIQUE COVID-19 VARIATIONS– only available in this Visiongain report are dedicated analysis of 4 different rebound scenarios of how the market will develop – no matter how COVID-19 affects the economy.
To access the data contained in this document please email contactus@visiongain.com
Forecasts to 2030 and other analyses reveal the commercial prospects
– In addition to revenue forecasting to 2030, our new study provides you with recent results, growth rates, and market shares, key player positioning, and an exhaustive product portfolio comparison of key vendors
– You find original analyses, with business outlooks and developments which would be useful to tap potential business areas for key players
– Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges, SWOT analysis), product profiles and commercial developments.
Which Factors are Fueling Topical drug delivery Industry Growth?
• High Prevalence of Skin Diseases
• High Prevalence of Eye Diseases
• High Incidence of Burn Injuries
• Increasing Prevalence of Diabetes
Which Factors are Restraining Growth?
• Preference for Alternative Modes of Drug Delivery
• Technical Barriers Related to Skin Irritation & Permeability
• Side Effects of Topical Drugs Due to Prolonged Application
How do prominent players strengthen their position throughout the world?
You must read this newly updated report if you are involved in this sector. The report from Visiongain gives you key potential revenues up to 2030, evaluates critical development information, trends, opportunities and business outlooks.
Forecasts to 2030 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2030, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), SWOT Analysis, Porter’s Analysis, product profiles and commercial developments.
Report Scope
Global Topical Drug Delivery Market 2020-2030 is segmented on the basis of Product, Route of Administration, End User and Geography.
• Revenue and growth forecasts from 2020 to 2030 for the Global Topical drug delivery Market by Product:
– Semi-Solid Formulations
o Creams
o Ointments
o Lotions
o Gels
o Pastes
– Liquid Formulations
o Suspensions
o Solutions
– Solid Formulations
o Powders
o Suppositories
– Transdermal Products
o Transdermal Patches
o Transdermal Semi-solids
• Revenue and growth forecasts from 2020 to 2030 for the Global Topical drug delivery Market by Route of Administration:
– Dermal Drug Delivery
– Ophthalmic Drug Delivery
– Rectal Drug Delivery
– Vaginal Drug Delivery
– Nasal Drug Delivery
• Revenue and growth forecasts from 2020 to 2030 for the Global Topical drug delivery Market by End-User:
– Home Care Settings
– Hospitals and Clinics
– Burn Centres
– Other Facilities
• Revenue and growth forecasts from 2020 to 2030 for the Global Topical drug delivery Market by Region:
– North America
• U.S.
• Canada
– Europe
• Germany
• France
• UK
• Italy
• Spain
• Rest of Europe
– Asia-Pacific
• Japan
• China
• India
• Australia
• Rest of APAC
– LAMEA
• Brazil
• Mexico
• Rest of LAMEA
Need industry data? Please contact us today.
• Our study discusses the selected leading companies that are the major players in the Topical drug delivery industry:
– GlaxoSmithKline
– Johnson & Johnson
– Bausch Health Companies
– Merck & Co.
– LEO Pharma
– Hisamitsu Pharmaceutical
– Novartis AG
– Glenmark Pharmaceuticals
– Cipla
– Mylan AV
How the Topical drug delivery Market report helps you
In summary, our 600+ page report provides you with the following knowledge:
– What is the current size of the overall global topical drug delivery market? How much will this market be worth from 2020 to 2030?
– What are the main drivers and restraints that will shape the overall topical drug delivery market over the next ten years?
– What are the main segments within the overall topical drug delivery market? How much will each of these segments be worth for the period 2020 to 2030? How will the composition of the market change during that time, and why?
– What factors will affect that industry and market over the next ten years?
– Which are the leading companies and what are their activities, results, developments, and prospects?
– What are the main trends that will affect the world topical drug delivery market between 2020 and 2030?
– What are the main strengths, weaknesses, opportunities, and threats for the market?
– How will the global topical drug delivery market evolve over the forecasted period, 2020 to 2030?
– Revenue forecasts to 2030 for 4 regional and 10 key national markets – the report highlights market growth prospects for key countries such as the U.S., Canada, Germany, UK, France, Italy, Spain, China, Japan, Australia, and India. The report also highlights growth potential in Latin America as well as Middle East & Africa.
– Prospects for established firms and those seeking to enter the market– including company profiles for over 10 of the major companies involved in the Topical drug delivery market
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Topical drug delivery Market and leading companies. You will find data, trends and predictions.
To access the data contained in this document please email contactus@visiongain.com
Buy our report today Topical Drug Delivery Market Report 2020-2030: Forecasts by Product (Semi-solid Formulations (Creams, Ointments, Lotions, Gels, Pastes)), (Liquid Formulations (Suspensions, Solutions)), Solid Formulations (Powders, Suppositories)), and (Transdermal Products (Transdermal Patches, Transdermal Semi-solids), and by Region (North America, Europe, Asia Pacific, Latin America and Middle East & Africa) PLUS Analysis of Leading Topical Drug Delivery Companies AND COVID-19 Recovery Scenarios. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1. Report Overview
1.1 Introduction
1.2 Why Should You Read This Report
1.3 What This Report Deliver?
1.4 Key Questions Answered by This Analytical Report
1.5 Who is this Report for?
1.6 Research Methodology
1.6.1 Primary Research
1.6.2 Secondary Research
1.6.3 Market Evaluation & Forecasting Methodology
1.7 Frequently Asked Questions (FAQ)
1.8 About Visiongain
2. Introduction To The Topical Drug Delivery Market
2.1 What is Topical Drug Delivery?
2.2 Global Topical Drug Delivery Market Segmentation
3. Executive Summary
3.1 High Prevalence Of Skin & Eye Diseases, High Incidence Of Burn Injuries, And The Growing Prevalence Of Diabetes to Fuel Market Growth
3.2 Stiff Competition Among Industry Players Owing to Highly Mature Market
3.3 Emerging Economies like Japan, China, and India Are Expected to Offer Lucrative Growth Opportunities
4. Qualitative Analysis of the Topical Drug Delivery Market
4.1 SWOT Analysis
4.2 PEST Analysis
4.3 Porter’s Five Forces Analysis
4.3.1 Bargaining Power of Supplier
4.3.2 High Bargaining Power of Buyer
4.3.3 Low Threat of New Entrants
4.3.4 Threat of Substitutes
4.3.5 Intensity of Competitive Rivalry
4.4 Market Trends
4.5 Market Dynamics
4.5.1 Driver
4.5.1.1 High Prevalence of Skin Diseases
4.5.1.2 High Prevalence of Eye Diseases
4.5.1.3 High Incidence of Burn Injuries
4.5.1.3 Increasing Prevalence of Diabetes
4.5.2 Restraints & Challenges
4.5.2.1 Preference for Alternative Modes of Drug Delivery
4.5.2.2 Technical Barriers Related to Skin Irritation & Permeability
4.5.2.3 Side Effects of Topical Drugs Due to Prolonged Application
4.5.2.4 Product Recall
4.5.2.5 Impact of COVID-19 Pandemic on Supply Chain
4.5.3 Opportunity
4.5.3.1 Delivery of Biologics Through the Transdermal Route
4.6 COVID-19 Impact Analysis
5. Global Topical Drug Delivery Market, By Product, 2020-2030
5.1 Global Topical Drug Delivery Market Forecast by Product, 2020-2030 (Pre COVID & Recovery Scenarios Included)
5.2 Semi-Solid Formulations Accounted for the Majority of the Market Share
5.2.1 Semi-Solid Formulations Topical Drug Delivery Market By Region: Market Forecast, 2020-2030
5.2.2 Semi-Solid Formulations Topical Drug Delivery Market By Product: Market Forecast, 2020-2030 (Pre COVID & Recovery Scenarios Included)
5.2.7 Creams Accounted for the Majority of the Market Share
5.2.7.1 Cream Topical Drug Delivery Market By Region: Market Forecast, 2020-2030
5.2.8 Ointment are commonly used to treat analgesic-related indications
5.2.8.1 Ointment Topical Drug Delivery Market By Region: Market Forecast, 2020-2030
5.2.9 Lotions segment is driven due to its ease of administration
5.2.9.1 Lotions Topical Drug Delivery Market By Region: Market Forecast, 2020-2030
5.2.10 Gels to Witness Highest Growth Rate Through 2030 owing to faster release of drug
5.2.10.1 Gels Topical Drug Delivery Market By Region: Market Forecast, 2020-2030
5.2.11 Paste are commonly adopted to treat and prevent skin irritation
5.2.11.1 Paste Topical Drug Delivery Market By Region: Market Forecast, 2020-2030
5.3 Liquid Formulations are driven owing to controlled drug action and high bioavailability rate
5.3.1 Liquid Formulations Topical Drug Delivery Market By Region: Market Forecast, 2020-2030
5.3.2 Liquid Formulations Topical Drug Delivery Market By Product: Market Forecast, 2020-2030 (Pre COVID & Recovery Scenarios Included)
5.3.7 Solutions Accounted for the Majority of the Market Share
5.3.7.1 Solutions Topical Drug Delivery Market By Region: Market Forecast, 2020-2030
5.3.8 Suspensions to Witness Highest Growth Rate Through 2030
5.3.8.1 Suspensions Topical Drug Delivery Market By Region: Market Forecast, 2020-2030
5.4 Solid Formulation are made of very fine particle size and need a suitable base
5.4.1 Solid Formulations Topical Drug Delivery Market By Region: Market Forecast, 2020-2030
5.4.2 Solid Formulations Topical Drug Delivery Market By Product: Market Forecast, 2020-2030 (Pre COVID & Recovery Scenarios Included)
5.4.7 Powders Accounted for the Majority of the Market Share
5.4.7.1 Powder Topical Drug Delivery Market By Region: Market Forecast, 2020-2030
5.4.8 Suppositories to Witness Highest Growth Rate Through 2030
5.4.8.1 Suppositories Topical Drug Delivery Market By Region: Market Forecast, 2020-2030
5.5 Transdermal Products are increasing in demand due to exclusive advantages and ease of administration
5.5.1 Transdermal Topical Drug Delivery Market By Region: Market Forecast, 2020-2030
5.5.2 Transdermal Products Topical Drug Delivery Market By Product: Market Forecast, 2020-2030 (Pre COVID & Recovery Scenarios Included)
5.5.7 Transdermal Patches Accounted for the Majority of the Market Share
5.5.7.1 Transdermal Patches Topical Drug Delivery Market By Region: Market Forecast, 2020-2030
5.5.8 Transdermal Semi-solids to Witness Highest Growth Rate Through 2030
5.5.8.1 Transdermal Semi-solids Topical Drug Delivery Market By Region: Market Forecast, 2020-2030
6. Global Topical Drug Delivery Market, By Route of Administration, 2020-2030
6.1 Global Topical Drug Delivery Market Forecast, by Route of Administration, 2020-2030 (Pre COVID & Recovery Scenarios Included)
6.2 Dermal Drug Delivery Accounted for the Majority of the Market Share
6.2.1 Topical Dermal Drug Delivery Market By Region: Market Forecast, 2020-2030
6.3 Ophthalmic Drug Delivery is increasingly being used due to increase in incidence of eye diseases
6.3.1 Topical Ophthalmic Drug Delivery Market By Region: Market Forecast, 2020-2030
6.4 Rectal Drug Delivery is not being commonly used due to poor drug absorption through this route
6.4.1 Topical Rectal Drug Delivery Market By Region: Market Forecast, 2020-2030
6.5 Vaginal Drug Delivery is being used owing to the high permeability of vaginal tissues
6.5.1 Topical Vaginal Drug Delivery Market By Region: Market Forecast, 2020-2030
6.6 Nasal Drug Delivery demand is increasing due to high efficacy of drugs administered through this route
6.6.1 Topical Nasal Drug Delivery Market By Region: Market Forecast, 2020-2030
7. Global Topical Drug Delivery Market, By End Users, 2020-2030
7.1 Global Topical Drug Delivery Market Forecast, 2020-2030 (Pre COVID & Recovery Scenarios Included)
7.2 Home Care Settings Accounted for the Majority of the Market Share
7.2.1 Topical Drug Delivery Market for home care settings By Region: Market Forecast, 2020-2030
7.3 Hospitals and Clinics segment is driven by the increase in incidence of surgical-site infections
7.3.1 Topical Drug Delivery Market for hospitals and clinics By Region: Market Forecast, 2020-2030
7.4 Burn Centers segment is driven by increase in incidence of burn injuries
7.4.1 Topical Drug Delivery Market for burn centers By Region: Market Forecast, 2020-2030
7.5 Other Facilities
7.5.1 Topical Drug Delivery Market for Other Facilities By Region: Market Forecast, 2020-2030
8. Leading National Markets Forecast 2020-2030
8.1. Geographical Breakdown of Global Topical Drug Delivery Market, 2020-2030 (Pre COVID & Recovery Scenarios Included)
9. North America Topical Drug Delivery Market, 2020-2030
9.1. North America Topical Drug Delivery Market Forecast, 2020-2030
9.2. North America Topical Drug Delivery Market By Product: Market Forecast, 2020-2030
9.2.1 North America Semi-Solid Formulations Topical Drug Delivery Market By Product: Market Forecast, 2020-2030
9.2.2 North America Liquid Formulations Topical Drug Delivery Market By Product: Market Forecast, 2020-2030
9.2.3 North America Solid Formulations Topical Drug Delivery Market By Product: Market Forecast, 2020-2030
9.2.4 North America Transdermal Products Topical Drug Delivery Market By Product: Market Forecast, 2020-2030
9.3. North America Topical Drug Delivery Market By Route of Administration: Market Forecast, 2020-2030
9.4. North America Topical Drug Delivery Market By End-User: Market Forecast, 2020-2030
9.5. North America Topical Drug Delivery Market By Country: Market Forecast, 2020-2030
9.6 US Accounted for the Majority of the Market Share
9.6.1 Increase in prevalence of skin diseases
9.6.2 High number of product launches and approvals
9.6.3 Recovery Scenarios (V, U, W, L)
9.7. Canada Topical Drug Delivery Market
9.7.1 Availability of funding to develop innovative topical drugs
9.7.2 Recovery Scenarios (V, U, W, L)
10. Europe Topical Drug Delivery Market, 2020-2030
10.1. Europe Topical Drug Delivery Market Forecast, 2020-2030
10.2. Europe Topical Drug Delivery Market By Product: Market Forecast, 2020-2030
10.2.1 Europe Semi-Solid Formulations Topical Drug Delivery Market By Product: Market Forecast, 2020-2030
10.2.2 Europe Liquid Formulations Topical Drug Delivery Market By Product: Market Forecast, 2020-2030
10.2.3 Europe Solid Formulations Topical Drug Delivery Market By Product: Market Forecast, 2020-2030
10.2.4 Europe Transdermal Products Topical Drug Delivery Market By Product: Market Forecast, 2020-2030
10.3. Europe Topical Drug Delivery Market By Route of Administration: Market Forecast, 2020-2030
10.4. Europe Topical Drug Delivery Market By End-User: Market Forecast, 2020-2030
10.5. Europe Topical Drug Delivery Market By Country: Market Forecast, 2020-2030
10.6. Germany Topical Drug Delivery Market, 2020-2030
10.6.1 Key players focusing on the development of topical products
10.6.2 Established Healthcare System
10.6.3 Recovery Scenarios (V, U, W, L)
10.7. France Topical Drug Delivery Market
10.7.1 Renowned Medical Care with Innovation
10.7.2 Development Of Topical Drugs By Local Players
10.7.3 Recovery Scenarios (V, U, W, L)
10.8. UK Topical Drug Delivery Market
10.8.1 Increase in prevalence of chronic conditions & skin diseases
10.8.2 145,000 people diagnosed with Parkinson’s disease in the UK
10.8.3 Recovery Scenarios (V, U, W, L)
10.9. Italy Topical Drug Delivery Market
10.9.1 Large Elderly Population
10.9.2 144,000 people diagnosed and living with Parkinson’s in Italy in 2016
10.9.3 Recovery Scenarios (V, U, W, L)
10.10. Spain Topical Drug Delivery Market
10.10.1 High Prevalence of Skin Conditions Across the Spanish Region
10.10.2 300,000 people diagnosed and living with Parkinson’s in Spain in 2016
10.10.3 Recovery Scenarios (V, U, W, L)
10.11. Rest of Europe Topical Drug Delivery Market
10.11.4 Recovery Scenarios (V, U, W, L)
11. Asia-Pacific Topical Drug Delivery Market, 2020-2030
11.1. Asia-Pacific Topical Drug Delivery Market Forecast, 2020-2030
11.2. Asia-Pacific Topical Drug Delivery Market By Product: Market Forecast, 2020-2030
11.2.1 Asia-Pacific Semi-Solid Formulations Topical Drug Delivery Market By Product: Market Forecast, 2020-2030
11.2.2 Asia-Pacific Liquid Formulations Topical Drug Delivery Market By Product: Market Forecast, 2020-2030
11.2.3 Asia-Pacific Solid Formulations Topical Drug Delivery Market By Product: Market Forecast, 2020-2030
11.2.4 Asia-Pacific Transdermal Products Topical Drug Delivery Market By Product: Market Forecast, 2020-2030
11.3. Asia-Pacific Topical Drug Delivery Market By Route of Administration: Market Forecast, 2020-2030
11.4. Asia-Pacific Topical Drug Delivery Market By End-User: Market Forecast, 2020-2030
11.5. Asia-Pacific Topical Drug Delivery Market By Country: Market Forecast, 2020-2030
11.6. Recovery Scenarios (V, U, W, L)
11.7 Japan Topical Drug Delivery Market
11.7.1. Increased R&D activities for the development of topical formulation among the local players
11.7.2. Ageing Population
11.7.3 Recovery Scenarios (V, U, W, L)
11.8 China Topical Drug Delivery Market
11.8.1 Presence of the large patient population
11.8.2 Increased focus of local and major players to develop topical drugs
11.8.3 Recovery Scenarios (V, U, W, L)
11.9 India Topical Drug Delivery Market
11.9.1 Rise in demand of non-invasive modes of drug delivery
11.9.2 Increased awareness regarding the benefits of using topical drugs
11.9.3 Recovery Scenarios (V, U, W, L)
11.10 Australia Topical Drug Delivery Market
11.10.1 Recovery Scenarios (V, U, W, L)
11.11 Rest of Asia-Pacific Topical Drug Delivery Market
11.11.1 Recovery Scenarios (V, U, W, L)
12. Latin America, Middle East & Africa (LAMEA) Topical Drug Delivery Market, 2020-2030
12.2. LAMEA Topical Drug Delivery Market By Product: Market Forecast, 2020-2030
12.2.1 LAMEA Semi-Solid Formulations Topical Drug Delivery Market By Product: Market Forecast, 2020-2030
12.2.2 LAMEA Liquid Formulations Topical Drug Delivery Market By Product: Market Forecast, 2020-2030
12.2.3 LAMEA Solid Formulations Topical Drug Delivery Market By Product: Market Forecast, 2020-2030
12.2.4 LAMEA Transdermal Products Topical Drug Delivery Market By Product: Market Forecast, 2020-2030
12.3. LAMEA Topical Drug Delivery Market By Route of Administration: Market Forecast, 2020-2030
12.4. LAMEA Topical Drug Delivery Market By End-User: Market Forecast, 2020-2030
12.5. LAMEA Topical Drug Delivery Market by Country: Market Forecast, 2020-2030
12.6. Recovery Scenarios (V, U, W, L)
12.7 Brazil Topical Drug Delivery Market
12.7.1 Recovery Scenarios (V, U, W, L)
12.8 Mexico Topical Drug Delivery Market
12.8.1 Recovery Scenarios (V, U, W, L)
12.9 Rest of LAMEA Topical Drug Delivery Market
12.9.1 Recovery Scenarios (V, U, W, L)
13. Leading Company in Topical Drug Delivery Market
13.1. GlaxoSmithKline
13.1.1 Company Overview
13.1.2 Product Portfolio
13.1.3 Sales Analysis
13.1.4 Strategies & Development
13.2. Johnson & Johnson
13.2.1 Company Overview
13.2.2 Product Portfolio
13.2.3 Sales Analysis
13.2.4 Strategies & Development
13.3. Bausch Health Companies.
13.3.1 Company Overview
13.3.2 Product Portfolio
13.3.3 Sales Analysis
13.3.4 Strategies & Development
13.4. Merck & Co.
13.4.1 Company Overview
13.4.2 Product Portfolio
13.4.3 Sales Analysis
13.5. LEO Pharma A/S
13.5.1 Company Overview
13.5.2 Product Portfolio
13.5.3 Sales Analysis
13.5.4 Strategies & Development
13.6. Hisamitsu Pharmaceutical Co. Inc.
13.6.1 Company Overview
13.6.2 Product Portfolio
13.6.3 Sales Analysis
13.6.4 Strategies & Development
13.7. Novartis AG.
13.7.1 Company Overview
13.7.2 Product Portfolio
13.7.3 Sales Analysis
13.7.4 Strategies & Development
13.8. Glenmark Pharmaceuticals
13.8.1 Company Overview
13.8.2 Product Portfolio
13.8.3 Sales Analysis
13.8.4 Strategies & Development
13.9. Cipla Limited.
13.8.1 Company Overview
13.9.2 Product Portfolio
13.9.3 Sales Analysis
13.9.4 Strategies & Development
13.10. Mylan N.V.
13.10.1 Company Overview
13.10.2 Product Portfolio
13.10.3 Sales Analysis
13.10.4 Strategies & Development
14. Conclusion & Recommendation
15. Glossary
List of Tables
Table. 1 Global Topical Drug Delivery Market, 2019 & 2030, Executive Summary (US$mn) & CAGR (%)
Table. 2 Global Topical Drug Delivery Market Revenue By Product(USD Mn), V-Shaped Recovery, 2020-2030
Table. 3 Global Topical Drug Delivery Market Revenue By Route of Administration (USD Mn), V-Shaped Recovery, 2020-2030
Table. 4 Global Topical Drug Delivery Market Revenue By End user (USD Mn), V-Shaped Recovery, 2020-2030
Table. 5 Global Topical Drug Delivery Market Revenue By Region (USD Mn), V-Shaped Recovery, 2020-2030
Table. 6
Table. 7 Global Topical Drug Delivery Market Revenue By Product (USD Mn), U-Shaped Recovery, 2020-2030
Table. 8 Global Topical Drug Delivery Market Revenue By Route of Administration (USD Mn), U-Shaped Recovery, 2020-2030
Table. 9 Global Topical Drug Delivery Market Revenue By End user (USD Mn), U-Shaped Recovery, 2020-2030
Table. 10 Global Topical Drug Delivery Market Revenue By Region (USD Mn), U-Shaped Recovery, 2020-2030
Table. 11 Global Topical Drug Delivery Market Revenue By Product (USD Mn), L-Shaped Recovery, 2020-2030
Table. 12 Global Topical Drug Delivery Market Revenue By Route of Administration (USD Mn), L-Shaped Recovery, 2020-2030
Table. 13 Global Topical Drug Delivery Market Revenue By End user (USD Mn), L-Shaped Recovery, 2020-2030
Table. 14 Global Topical Drug Delivery Market Revenue By Region (USD Mn), L-Shaped Recovery, 2020-2030
Table. 15
Table. 16 Global Topical Drug Delivery Market Revenue By Product (USD Mn), W-Shaped Recovery, 2020-2030
Table. 17 Global Topical Drug Delivery Market Revenue By Route of Administration (USD Mn), W-Shaped Recovery, 2020-2030
Table. 18 Global Topical Drug Delivery Market Revenue By End user (USD Mn), W-Shaped Recovery, 2020-2030
Table. 19 Global Topical Drug Delivery Market Revenue By Region (USD Mn), W-Shaped Recovery, 2020-2030
Table. 20 Global Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 21 Global Semi-Solid Formulation Topical Drug Delivery Market Revenue By Region (USD Mn), 2020-2030
Table. 22 Global Semi-Solid Formulation Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 23 Global Cream Topical Drug Delivery Market Revenue, By Region (USD Mn), 2020-2030
Table. 24 Global Ointment Topical Drug Delivery Market Revenue, By Region (USD Mn), 2020-2030
Source: Visiongain 2020
Table. 25 Global Lotions Topical Drug Delivery Market Revenue, By Region (USD Mn), 2020-2030
Table. 26 Global Gels Topical Drug Delivery Market Revenue, By Region (USD Mn), 2020-2030
Table. 27 Global Paste Topical Drug Delivery Market Revenue, By Region (USD Mn), 2020-2030
Table. 28 Global Liquid Formulation Topical Drug Delivery Market Revenue By Region (USD Mn), 2020-2030
Table. 29
Table. 30 Global Liquid Formulation Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 31 Global Solutions Topical Drug Delivery Market Revenue, By Region (USD Mn), 2020-2030
Table. 32 Global Suspensions Topical Drug Delivery Market Revenue, By Region (USD Mn), 2020-2030
Source: Visiongain 2020
Table. 33 Global Solid Formulation Topical Drug Delivery Market Revenue By Region (USD Mn), 2020-2030
Table. 34 Global Solid Formulation Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 35 Global Powder Topical Drug Delivery Market Revenue, By Region (USD Mn), 2020-2030
Table. 36 Global Suppositories Topical Drug Delivery Market Revenue, By Region (USD Mn), 2020-2030
Table. 37 Global Transdermal Topical Drug Delivery Market Revenue By Region (USD Mn), 2020-2030
Table. 38 Global Transdermal Products Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 39 Global Transdermal Patches Topical Drug Delivery Market Revenue, By Region (USD Mn), 2020-2030
Table. 40 Global Transdermal Semi-solids Topical Drug Delivery Market Revenue, By Region (USD Mn), 2020-2030
Table. 41 Global Topical Drug Delivery Market Revenue, By Route of Administration (USD Mn), 2020-2030
Table. 42 Global Topical Dermal Drug Delivery Market Revenue, By Region (USD Mn), 2020-2030
Table. 43 Global Topical Ophthalmic Drug Delivery Market Revenue, By Region (USD Mn), 2020-2030
Table. 44 Global Topical Rectal Drug Delivery Market Revenue, By Region (USD Mn), 2020-2030
Table. 45 Global Topical Vaginal Drug Delivery Market Revenue, By Region (USD Mn), 2020-2030
Table. 46 Global Topical Nasal Drug Delivery Market Revenue, By Region (USD Mn), 2020-2030
Table. 47 Global Topical Drug Delivery Market Revenue, By End User (USD Mn), 2020-2030
Table. 48 Global Topical Rectal Drug Delivery Market Revenue for home care settings, By Region (USD Mn), 2020-2030
Table. 49 Global Topical Drug Delivery Market Revenue for hospitals and clinics, By Region (USD Mn), 2020-2030
Table. 50 Global Topical Rectal Drug Delivery Market Revenue for burn centers, By Region (USD Mn), 2020-2030
Table. 51 Global Topical Drug Delivery Market Revenue for Other Facilities, By Region (USD Mn), 2020-2030
Table. 52 Global Topical Drug Delivery Market Revenue, By Region (USD Mn), 2020-2030
Table. 53 North America Topical Drug Delivery Market Revenue, By Product (USD Mn), 2020-2030
Table. 54 North America Semi-Solid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 55 North America Liquid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 56 North America Solid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 57 North America Transdermal Products Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 58 North America Topical Drug Delivery Market Revenue, By Route of Administration (USD Mn), 2020-2030
Table. 59 North America Topical Drug Delivery Market Revenue, By End-User (USD Mn), 2020-2030
Table. 60 North America Topical Drug Delivery Market Revenue, By Country (USD Mn), 2020-2030
Table. 61 US Topical Drug Delivery Market Revenue, By Product (USD Mn), 2020-2030
Table. 62 US Semi-solid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 63 US Liquid Formulation Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 64 US Solid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 65 US Transdermal Product Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 66 US Topical Drug Delivery Market Revenue, By Route of Administration (USD Mn), 2020-2030
Table. 67 US Topical Drug Delivery Market Revenue, By End-User (USD Mn), 2020-2030
Table. 68 Canada Topical Drug Delivery Market Revenue, By Product (USD Mn), 2020-2030
Table. 69 Canada Semi-solid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 70 Canada Liquid Formulation Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 71 Canada Solid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 72 Canada Transdermal Product Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 73 Canada Topical Drug Delivery Market Revenue, By Route of Administration (USD Mn), 2020-2030
Table. 74 Canada Topical Drug Delivery Market Revenue, By End-User (USD Mn), 2020-2030
Table. 75 Europe Topical Drug Delivery Market Revenue, By Product (USD Mn), 2020-2030
Table. 76 Europe Semi-Solid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 77 Europe Liquid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 78 Europe Solid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 79 Europe Transdermal Products Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 80 Europe Topical Drug Delivery Market Revenue, By Route of Administration (USD Mn), 2020-2030
Table. 81 Europe Topical Drug Delivery Market Revenue, By End-User (USD Mn), 2020-2030
Table. 82 Europe Topical Drug Delivery Market Revenue, By Country (USD Mn), 2020-2030
Table. 83 Germany Topical Drug Delivery Market Revenue, By Product (USD Mn), 2020-2030
Table. 84 Germany Semi-solid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 85 Germany Liquid Formulation Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 86 Germany Solid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 87 Germany Transdermal Product Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 88 Germany Topical Drug Delivery Market Revenue, By Route of Administration (USD Mn), 2020-2030
Table. 89 Germany Topical Drug Delivery Market Revenue, By End-User (USD Mn), 2020-2030
Table. 90 France Topical Drug Delivery Market Revenue, By Product (USD Mn), 2020-2030
Table. 91 France Semi-solid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 92 France Liquid Formulation Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 93 France Solid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 94 France Transdermal Product Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 95 France Topical Drug Delivery Market Revenue, By Route of Administration (USD Mn), 2020-2030
Table. 96 France Topical Drug Delivery Market Revenue, By End-User (USD Mn), 2020-2030
Table. 97 UK Topical Drug Delivery Market Revenue, By Product (USD Mn), 2020-2030
Table. 98 UK Semi-solid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 99 UK Liquid Formulation Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 100 UK Solid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 101 UK Transdermal Product Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 102 UK Topical Drug Delivery Market Revenue, By Route of Administration (USD Mn), 2020-2030
Table. 103 UK Topical Drug Delivery Market Revenue, By End-User (USD Mn), 2020-2030
Table. 104 Italy Topical Drug Delivery Market Revenue, By Product (USD Mn), 2020-2030
Table. 105 Italy Semi-solid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 106 Italy Liquid Formulation Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 107 Italy Solid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 108 Italy Transdermal Product Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 109 Italy Topical Drug Delivery Market Revenue, By Route of Administration (USD Mn), 2020-2030
Table. 110 Italy Topical Drug Delivery Market Revenue, By End-User (USD Mn), 2020-2030
Table. 111 Spain Topical Drug Delivery Market Revenue, By Product (USD Mn), 2020-2030
Table. 112 Spain Semi-solid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 113 Spain Liquid Formulation Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 114 Spain Solid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 115 Spain Transdermal Product Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 116 Spain Topical Drug Delivery Market Revenue, By Route of Administration (USD Mn), 2020-2030
Table. 117 Spain Topical Drug Delivery Market Revenue, By End-User (USD Mn), 2020-2030
Table. 118 Rest of Europe Topical Drug Delivery Market Revenue, By Product (USD Mn), 2020-2030
Table. 119 Rest of Europe Semi-solid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 120 Rest of Europe Liquid Formulation Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 121 Rest of Europe Solid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 122 Rest of Europe Transdermal Product Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 123 Rest of Europe Topical Drug Delivery Market Revenue, By Route of Administration (USD Mn), 2020-2030
Table. 124 Rest of Europe Topical Drug Delivery Market Revenue, By End-User (USD Mn), 2020-2030
Table. 125 Asia-Pacific Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 126 Asia-Pacific Semi-Solid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 127 Asia-Pacific Liquid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 128 Asia-Pacific Solid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 129 Asia-Pacific Transdermal Products Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 130 Asia-Pacific Topical Drug Delivery Market Revenue By Route of Administration (USD Mn), 2020-2030
Table. 131 Asia-Pacific Topical Drug Delivery Market Revenue By End-User (USD Mn), 2020-2030
Table. 132 Asia-Pacific Topical Drug Delivery Market Revenue By Country (USD Mn), 2020-2030
Table. 133 Japan Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 134 Japan Semi-solid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 135 Japan Liquid Formulation Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 136 Japan Solid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 137 Japan Transdermal Product Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 138 Japan Topical Drug Delivery Market Revenue By Route of Administration (USD Mn), 2020-2030
Table. 139 Japan Topical Drug Delivery Market Revenue By End-user (USD Mn), 2020-2030
Table. 140 China Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 141 China Semi-solid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 142 China Liquid Formulation Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 143 China Solid Formulation Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 144 China Transdermal Product Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 145 China Topical Drug Delivery Market Revenue By Route of Administration (USD Mn), 2020-2030
Table. 146 China Topical Drug Delivery Market Revenue By End-user (USD Mn), 2020-2030
Table. 147 India Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 148 India Semi-solid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 149 India Liquid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 150 India Solid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 151 India Transdermal Products Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 152 India Topical Drug Delivery Market Revenue By Route of Administration (USD Mn), 2020-2030
Table. 153 India Topical Drug Delivery Market Revenue By End-user (USD Mn), 2020-2030
Table. 154 Australia Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 155 Australia Semi-solid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 156 Australia Liquid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 157 Australia Solid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 158 Australia Transdermal Products Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 159 Australia Topical Drug Delivery Market Revenue By Route of Administration (USD Mn), 2020-2030
Table. 160 Australia Topical Drug Delivery Market Revenue By End-user (USD Mn), 2020-2030
Table. 161 Rest of Asia-Pacific Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 162 Rest of APAC Semi-solid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 163 Rest of APAC Liquid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 164 Rest of APAC Soild Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 165 Rest of APAC Transdermal Products Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 166 Rest of Asia-Pacific Topical Drug Delivery Market Revenue By Route of Administration (USD Mn), 2020-2030
Table. 167 Rest of Asia-Pacific Topical Drug Delivery Market Revenue By End-user (USD Mn), 2020-2030
Table. 168 LAMEA Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 169 LAMEA Semi-solid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 170 LAMEA Liquid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 171 LAMEA Solid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 172 LAMEA Transdermal Product Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 173 LAMEA Topical Drug Delivery Market Revenue By Route of Administration (USD Mn), 2020-2030
Table. 174 LAMEA Topical Drug Delivery Market Revenue By End-user (USD Mn), 2020-230
Table. 175 LAMEA Topical Drug Delivery Market Revenue By Country (USD Mn), 2020-2030
Table. 176 Brazil Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 177 Brazil Semi-solid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 178 Brazil Liquid Formuations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 179 Brazil Solid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 180 Brazil Transdermal Products Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 181 Brazil Topical Drug Delivery Market Revenue By Route of Administration (USD Mn), 2020-2030
Table. 182 Brazil Topical Drug Delivery Market Revenue By End-user (USD Mn), 2020-2030
Table. 183 Mexico Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 184 Mexico Semi-Solid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 185 Mexico Liquid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 186 Mexico Solid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 187 Mexico Transdermal Products Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 188 Mexico Topical Drug Delivery Market Revenue By Route of Administration (USD Mn), 2020-2030
Table. 189 Mexico Topical Drug Delivery Market Revenue By End-user (USD Mn), 2020-2030
Table. 190 Rest of LAMEA Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 191 Rest of LAMEA Semi-solid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 192 Rest of LAMEA Liquid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 193 Rest of LAMEA Solid Formulations Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 194 Rest of LAMEA Transdermal Products Topical Drug Delivery Market Revenue By Product (USD Mn), 2020-2030
Table. 195 Rest of LAMEA Topical Drug Delivery Market Revenue By Route of Administration (USD Mn), 2020-2030
Table. 196 Rest of LAMEA Topical Drug Delivery Market Revenue By End-user (USD Mn), 2020-2030
Table. 197 GlaxoSmithKline Company Overview
Table. 198 GlaxoSmithKline Product Portfolio
Table. 199 Product Portfolio
Table. 200 Johnson & Johnson Product Portfolio
Table. 201 Johnson & Johnson Product Portfolio
Table. 202 Johnson & Johnson Strategies aand Development
Table. 203 Baush Health Company Overview
Table. 204 Baush Health Company Product Portfolio
Table. 205 Baush Health Company Strategies & Development
Table. 206 Merck & Co. Overview
Merck & Co. Product Portfolio
Table. 207 Merxk & Co. Product Portfolio
Table. 208 Leo Pharma A/S Overview
Table. 209 Leo Pharma A/S Product Portfolio
Table. 210 Leo Pharma A/S Strategies & Development
Table. 211 Hisamitsu Pharmaceutical Co. Inc. Overview
Table. 212 Hisamitsu Pharmaceutical Co. Inc. Product Portfolio
Table. 213 Hisamitsu Pharmaceutical Co. Inc. Strategies & Development
Table. 214 Novartis AG. Overview
Table. 215 Novartis AG. Product Portfolio
Table. 216 Novartis AG. Strategies & Development
Table. 217 Glenmark Pharmaceuticals Overview
Table. 218 Glenmark Pharmaceuticals Product Portfolio
Table. 219 Glenmark Pharmaceuticals Strategies & Development
Table. 220 Cipla Limited Overview
Table. 221 Cipla Limited Product Portfolio
Table. 222 Cipla Limited Strategies & development
Table. 223 Mylan N.V. Overview
Table. 224 Mylan N.V. Product Portfolio
Table. 225 Mylan N.V. Strategies & Development
List of Figures
FIG. 1 Global Topical Drug Delivery Market (USD Million), 2019-2030
FIG. 2 Global Topical Drug Delivery Market Value Share (%), by Region, (2019 & 2030)
FIG. 3 Global Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 4 Global Topical Drug Delivery Market Value Share (%), by Route of Administration, (2019 & 2030)
FIG. 5 Global Topical Drug Delivery Market Value Share (%), by End-User, (2019 & 2030)
FIG. 6 Low Bargaining Power of Supplier
FIG. 7 High Bargaining Power of Buyer
FIG. 8 Low Threat of New Entrants
FIG. 9 Low Threat of Substitutes
FIG. 10 High Intensity Of Competitive Rivalry
FIG. 11 COVID-19 Impact on Global Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
FIG. 12 COVID-19 Impact on Global Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
FIG. 13 COVID-19 Impact on Global Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
FIG. 14 COVID-19 Impact on Global Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
FIG. 15 Global Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 16 Global Semi-Solid Formulation Topical Drug Delivery Market Value Share (%), by Region, (2019 & 2030)
FIG. 17 Global Semi-Solid Formulation Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 18 COVID-19 Impact on Semi-Solid Formulations Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
FIG. 19 COVID-19 Impact on Semi-Solid Formulations Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
FIG. 20 COVID-19 Impact on Semi-Solid Formulations Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
FIG. 21 COVID-19 Impact on Semi-Solid Formulations Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
FIG. 22 Global Cream Topical Drug Delivery Market Value Share (%), by Region, (2019 & 2030)
FIG. 23 COVID-19 Impact on Cream Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
FIG. 24 COVID-19 Impact on Cream Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
FIG. 25 COVID-19 Impact on Cream Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
FIG. 26 COVID-19 Impact on Cream Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
FIG. 27 Global Ointment Topical Drug Delivery Market Value Share (%), by Region, (2019 & 2030)
FIG. 28 COVID-19 Impact on Ointment Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
FIG. 29 COVID-19 Impact on Ointment Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
FIG. 30 COVID-19 Impact on Ointment Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
FIG. 31 COVID-19 Impact on Ointment Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
FIG. 32 Global Lotion Topical Drug Delivery Market Value Share (%), by Region, (2019 & 2030)
FIG. 33 COVID-19 Impact on Lotions Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
FIG. 34 COVID-19 Impact on Lotions Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
FIG. 35 COVID-19 Impact on Lotions Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
FIG. 36 COVID-19 Impact on Lotions Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
FIG. 37 Global Gels Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 38 COVID-19 Impact on Gels Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
FIG. 39 COVID-19 Impact on Gels Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
FIG. 40 COVID-19 Impact on Gels Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
FIG. 41 COVID-19 Impact on Gels Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
FIG. 42 Global Paste Topical Drug Delivery Market Value Share (%), by Region, (2019 & 2030)
FIG. 43 COVID-19 Impact on Paste Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
FIG. 44 COVID-19 Impact on Paste Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
FIG. 45 COVID-19 Impact on Paste Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
FIG. 46 COVID-19 Impact on Paste Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
FIG. 47 Global Liquid Formulation Topical Drug Delivery Market Value Share (%), by Region, (2019 & 2030)
FIG. 48 Global Semi-Solid Formulation Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 49 COVID-19 Impact on Liquid Formulations Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
FIG. 50 COVID-19 Impact on Liquid Formulations Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
FIG. 51 COVID-19 Impact on Liquid Formulations Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
FIG. 52 COVID-19 Impact on Liquid Formulations Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
FIG. 53 Global Solutions Topical Drug Delivery Market Value Share (%), by Region, (2019 & 2030)
FIG. 54 COVID-19 Impact on Solutions Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
FIG. 55 COVID-19 Impact on Solutions Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
FIG. 56 COVID-19 Impact on Solutions Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
FIG. 57 COVID-19 Impact on Solutions Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
FIG. 58 Global Suspensions Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 59 COVID-19 Impact on Suspensions Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
FIG. 60 COVID-19 Impact on Suspensions Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
FIG. 61 COVID-19 Impact on Suspensions Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
FIG. 62 COVID-19 Impact on Suspensions Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
FIG. 63 Global Solid Formulation Topical Drug Delivery Market Value Share (%), by Region, (2019 & 2030)
FIG. 64 Global Solid Formulation Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 65 COVID-19 Impact on Solid Formulations Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
FIG. 66 COVID-19 Impact on Solid Formulations Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
FIG. 67 COVID-19 Impact on Solid Formulations Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
FIG. 68 COVID-19 Impact on Solid Formulations Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
FIG. 69 Global Powder Topical Drug Delivery Market Value Share (%), by Region, (2019 & 2030)
FIG. 70 COVID-19 Impact on Powders Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
FIG. 71 COVID-19 Impact on Powders Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
FIG. 72 COVID-19 Impact on Powder Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
FIG. 73 COVID-19 Impact on Powders Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
FIG. 74 Global SuppositoriesTopical Drug Delivery Market Value Share (%), by Region, (2019 & 2030)
FIG. 75 COVID-19 Impact on Suppositories Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
FIG. 76 COVID-19 Impact on Suppositories Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
FIG. 77 COVID-19 Impact on Suppositories Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
FIG. 78 COVID-19 Impact on Suppositories Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
FIG. 79 Global Transdermal Topical Drug Delivery Market Value Share (%), by Region, (2019 & 2030)
FIG. 80 Global Transdermal Products Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 81 COVID-19 Impact on Transdermal Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
FIG. 82 COVID-19 Impact on Transdermal Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
FIG. 83 COVID-19 Impact on Transdermal Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
FIG. 84 COVID-19 Impact on Transdermal Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
FIG. 85 Global Transdermal Patches Topical Drug Delivery Market Value Share (%), by Region, (2019 & 2030)
FIG. 86 COVID-19 Impact on Transdermal Patches Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
FIG. 87 COVID-19 Impact on Transdermal Patches Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
FIG. 88 COVID-19 Impact on Transdermal Patches Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
FIG. 89 COVID-19 Impact on Transdermal Patches Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
FIG. 90 Global Transdermal Semi-solids Topical Drug Delivery Market Value Share (%), by Region, (2019 & 2030)
FIG. 91 COVID-19 Impact on Transdermal Semi-solids Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
FIG. 92 COVID-19 Impact on Transdermal Semi-solids Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
FIG. 93 COVID-19 Impact on Transdermal Semi-solids Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
FIG. 94 COVID-19 Impact on Transdermal Semi-Solids Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
FIG. 95 Global Topical Drug Delivery Market Value Share (%), by Route of Administration, (2019 & 2030)
FIG. 96 Global Topical Dermal Drug Delivery Market Value Share (%), by Region, (2019 & 2030)
FIG. 97 COVID-19 Impact on Topical Dermal Drug Delivery Market (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
FIG. 98 COVID-19 Impact on Topical Dermal Drug Delivery Market (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
FIG. 99 COVID-19 Impact on Topical Dermal Drug Delivery Market (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
FIG. 100 COVID-19 Impact on Topical Dermal Drug Delivery Market (USD Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
FIG. 101 Global Topical Ophthalmic Drug Delivery Market Value Share (%), by Region, (2019 & 2030)
FIG. 102 COVID-19 Impact on Topical Ophthalmic Drug Delivery Market (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
FIG. 103 COVID-19 Impact on Topical Ophthalmic Drug Delivery Market (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
FIG. 104 COVID-19 Impact on Topical Ophthalmic Drug Delivery Market (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
FIG. 105 COVID-19 Impact on Topical Ophthalmic Drug Delivery Market (USD Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
FIG. 106 Global Topical Rectal Drug Delivery Market Value Share (%), by Region, (2019 & 2030)
FIG. 107 COVID-19 Impact on Topical Rectal Drug Delivery Market (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
FIG. 108 COVID-19 Impact on Topical Rectal Drug Delivery Market (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
FIG. 109 COVID-19 Impact on Topical Rectal Drug Delivery Market (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
FIG. 110 COVID-19 Impact on Topical Rectal Drug Delivery Market (USD Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
FIG. 111 Global Topical Vaginal Drug Delivery Market Value Share (%), by Region, (2019 & 2030)
FIG. 112 COVID-19 Impact on Topical Vaginal Drug Delivery Market (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
FIG. 113 COVID-19 Impact on Topical Vaginal Drug Delivery Market (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
FIG. 114 COVID-19 Impact on Topical Vaginal Drug Delivery Market (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
FIG. 115 COVID-19 Impact on Topical Vaginal Drug Delivery Market (USD Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
FIG. 116 Global Topical Nasal Drug Delivery Market Value Share (%), by Region, (2019 & 2030)
FIG. 117 COVID-19 Impact on Topical Nasal Drug Delivery Market (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
FIG. 118 COVID-19 Impact on Topical Nasal Drug Delivery Market (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
FIG. 119 COVID-19 Impact on Topical Nasal Drug Delivery Market (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
FIG. 120 COVID-19 Impact on Topical Nasal Drug Delivery Market (USD Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
FIG. 121 Global Topical Drug Delivery Market Value Share (%), by End User, (2019 & 2030)
FIG. 122 Global Topical Drug Delivery Market for home care settings Value Share (%), by Region, (2019 & 2030)
FIG. 123 COVID-19 Impact on Topical Drug Delivery Market for Home care settings (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
FIG. 124 COVID-19 Impact on Topical Drug Delivery Market for home care settings (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
FIG. 125 COVID-19 Impact on Topical Drug Delivery Market for home care settings (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
FIG. 126 COVID-19 Impact on Topical Drug Delivery Market for home care settings (USD Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
FIG. 127 Global Topical Drug Delivery Market for hospitals and clinics Value Share (%), by Region, (2019 & 2030)
FIG. 128 COVID-19 Impact on Topical Drug Delivery Market for Hospitals & clinics (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
FIG. 129 COVID-19 Impact on Topical Drug Delivery Market for Hospitals & clinics (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
FIG. 130 COVID-19 Impact on Topical Drug Delivery Market for Hospitals & clinics (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
FIG. 131 COVID-19 Impact on Topical Drug Delivery Market for Hospitals & clinics (USD Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
FIG. 132 Global Topical Drug Delivery Market Value Share (%) for burn centers, by Region, (2019 & 2030)
FIG. 133 COVID-19 Impact on Topical Drug Delivery Market for Burn centers (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
FIG. 134 COVID-19 Impact on Topical Drug Delivery Market for Burn centers (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
FIG. 135 COVID-19 Impact on Topical Drug Delivery Market for Burn centers (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
FIG. 136 COVID-19 Impact on Topical Drug Delivery Market for Burn centers (USD
FIG. 137 Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
FIG. 138 Global Topical Drug Delivery Market Value Share (%) for Other Facilities, by Region, (2019 & 2030)
FIG. 139 COVID-19 Impact on Topical Drug Delivery Market for Other facilities (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
FIG. 140 COVID-19 Impact on Topical Drug Delivery Market for Other facilities (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
FIG. 141 COVID-19 Impact on Topical Drug Delivery Market for Other facilities (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
FIG. 142 COVID-19 Impact on Topical Drug Delivery Market for Other facilities (USD Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
FIG. 143 Global Topical Drug Delivery Market Value Share (%), by Region, (2019 & 2030)
FIG. 144 North America Topical Drug Delivery Market (USD Million), 2019-2030
FIG. 145 North America Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 146 North America Semi-Solid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 147 North America Liquid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 148 North America Solid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 149 North America Transdermal products Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 150 North America Topical Drug Delivery Market Value Share (%), by Route of Administration, (2019 & 2030)
FIG. 151 North America Topical Drug Delivery Market Value Share (%), by End User, (2019 & 2030)
FIG. 152 North America Topical Drug Delivery Market Value Share (%), by Country, (2019 & 2030)
FIG. 153 COVID-19 Impact on North America Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
FIG. 154 COVID-19 Impact on North America Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
FIG. 155 COVID-19 Impact on North America Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
FIG. 156 COVID-19 Impact on North America Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
FIG. 157 US Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 158 US Semi-Solid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 159 US Liquid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 160 US Solid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 161 US Transdermal Products Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 162 US Topical Drug Delivery Market Value Share (%), by Route of Administration, (2019 & 2030)
FIG. 163 US Topical Drug Delivery Market Value Share (%), by End-User, (2019 & 2030)
FIG. 164 COVID-19 Impact on US Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
FIG. 165 COVID-19 Impact on US Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
FIG. 166 COVID-19 Impact on US Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
FIG. 167 COVID-19 Impact on US Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
FIG. 168 Canada Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 169 Canada Semi-Solid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 170 Canada Liquid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 171 Canada Solid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 172 Canada Transdermal Products Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 173 Canada Topical Drug Delivery Market Value Share (%), by Route of Administration, (2019 & 2030)
FIG. 174 Canada Topical Drug Delivery Market Value Share (%), by End-User, (2019 & 2030)
FIG. 175 COVID-19 Impact on Canada Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
FIG. 176 COVID-19 Impact on Canada Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
FIG. 177 COVID-19 Impact on Canada Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
FIG. 178 COVID-19 Impact on Canada Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
FIG. 179 Europe Topical Drug Delivery Market (USD Million), 2019-2030
FIG. 180 Europe Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 181 Europe Semi-Solid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 182 Europe Liquid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 183 Europe Solid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 184 Europe Transdermal products Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 185 Europe Topical Drug Delivery Market Value Share (%), by Route of Administration, (2019 & 2030)
FIG. 186 Europe Topical Drug Delivery Market Value Share (%), by End-User, (2019 & 2030)
FIG. 187 Europe Topical Drug Delivery Market Value Share (%), by Country, (2019 & 2030)
FIG. 188 COVID-19 Impact on Europe Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
FIG. 189 COVID-19 Impact on Europe Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
FIG. 190 COVID-19 Impact on Europe Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
FIG. 191 COVID-19 Impact on Europe Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
FIG. 192 Germany Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 193 Germany Semi-Solid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 194 Germany Liquid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 195 Germany Solid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 196 Germany Transdermal Products Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 197 Germany Topical Drug Delivery Market Value Share (%), by Route of Administration, (2019 & 2030)
FIG. 198 Germany Topical Drug Delivery Market Value Share (%), by End-User, (2019 & 2030)
FIG. 199 COVID-19 Impact on Germany Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
FIG. 200 COVID-19 Impact on Germany Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
FIG. 201 COVID-19 Impact on Germany Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
FIG. 202 COVID-19 Impact on Germany Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
FIG. 203 France Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 204 France Semi-Solid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 205 France Liquid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 206 France Solid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 207 France Transdermal Products Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 208 France Topical Drug Delivery Market Value Share (%), by Route of Administration, (2019 & 2030)
FIG. 209 France Topical Drug Delivery Market Value Share (%), by End-User, (2019 & 2030)
FIG. 210 COVID-19 Impact on France Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
FIG. 211 COVID-19 Impact on France Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
FIG. 212 COVID-19 Impact on France Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
FIG. 213 COVID-19 Impact on France Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
FIG. 214 UK Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 215 UK Semi-Solid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 216 UK Liquid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 217 UK Solid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 218 UK Transdermal Products Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 219 UK Topical Drug Delivery Market Value Share (%), by Route of Administration, (2019 & 2030)
FIG. 220 UK Topical Drug Delivery Market Value Share (%), by End User, (2019 & 2030)
FIG. 221 COVID-19 Impact on UK Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
FIG. 222 COVID-19 Impact on UK Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
FIG. 223 COVID-19 Impact on UK Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
FIG. 224 COVID-19 Impact on UK Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
FIG. 225 Italy Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 226 Italy Semi-Solid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 227 Italy Liquid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 228 Italy Solid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 229 Italy Transdermal Products Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 230 Italy Topical Drug Delivery Market Value Share (%), by Route of Administration, (2019 & 2030)
FIG. 231 Italy Topical Drug Delivery Market Value Share (%), by End-User, (2019 & 2030)
FIG. 232 COVID-19 Impact on Italy Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
FIG. 233 COVID-19 Impact on Italy Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
FIG. 234 COVID-19 Impact on Italy Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
FIG. 235 COVID-19 Impact on Italy Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
FIG. 236 Spain Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 237 Spain Semi-Solid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 238 Spain Liquid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 239 Spain Solid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 240 Spain Transdermal Products Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 241 Spain Topical Drug Delivery Market Value Share (%), by Route of Administration, (2019 & 2030)
FIG. 242 Spain Topical Drug Delivery Market Value Share (%), by End-User, (2019 & 2030)
FIG. 243 COVID-19 Impact on Spain Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
FIG. 244 COVID-19 Impact on Spain Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
FIG. 245 COVID-19 Impact on Spain Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
FIG. 246 COVID-19 Impact on Spain Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
FIG. 247 Rest of Europe Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 248 Rest of Europe Semi-Solid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 249 Rest of Europe Liquid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 250 Rest of Europe Solid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 251 Rest of Europe Transdermal Products Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 252 Rest of Europe Topical Drug Delivery Market Value Share (%), by Route of Administration, (2019 & 2030)
FIG. 253 Rest of Europe Topical Drug Delivery Market Value Share (%), by End User, (2019 & 2030)
FIG. 254 COVID-19 Impact on Rest of Europe Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
FIG. 255 COVID-19 Impact on Rest of Europe Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
FIG. 256 COVID-19 Impact on Rest of Europe Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
FIG. 257 COVID-19 Impact on Rest of Europe Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
FIG. 258 Asia-Pacific Topical Drug Delivery Market (USD Million), 2019-2030
FIG. 259 Asia-Pacific Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 260 Asia-Pacific Semi-Solid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 261 Asia-Pacific Liquid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 262 Asia-Pacific Solid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 263 Asia-Pacific Transdermal products Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 264 Asia-Pacific Topical Drug Delivery Market Value Share (%), by Route of Administration, (2019 & 2030)
FIG. 265 Asia-Pacific Topical Drug Delivery Market Value Share (%), by End-user, (2019 & 2030)
FIG. 266 Asia-Pacific Topical Drug Delivery Market Value Share (%), by Country, (2019 & 2030)
FIG. 267 COVID-19 Impact on Asia-Pacific Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
FIG. 268 COVID-19 Impact on Asia-Pacific Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
FIG. 269 COVID-19 Impact on Asia-Pacific Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
FIG. 270 COVID-19 Impact on Asia-Pacific Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
FIG. 271 Japan Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 272 Japan Semi-Solid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 273 Japan Liquid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 274 Japan Solid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 275 Japan Transdermal Products Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 276 Japan Topical Drug Delivery Market Value Share (%), by Route of Administration, (2019 & 2030)
FIG. 277 Japan Topical Drug Delivery Market Value Share (%), by End-User, (2019 & 2030)
FIG. 278 COVID-19 Impact on Japan Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
FIG. 279 COVID-19 Impact on Japan Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
FIG. 280 COVID-19 Impact on Japan Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
FIG. 281 COVID-19 Impact on Japan Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
FIG. 282 China Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 283 China Semi-Solid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 284 China Liquid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 285 China Solid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 286 China Transdermal Products Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 287 China Topical Drug Delivery Market Value Share (%), by Route of Administration, (2019 & 2030)
FIG. 288 China Topical Drug Delivery Market Value Share (%), by End-User, (2019 & 2030)
FIG. 289 COVID-19 Impact on China Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
FIG. 290 COVID-19 Impact on China Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
FIG. 291 COVID-19 Impact on China Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
FIG. 292 COVID-19 Impact on China Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
FIG. 293 India Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 294 India Semi-Solids Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 295 India Liquid Formulation Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 296 India Solid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 297 India Transdermal Products Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 298 India Topical Drug Delivery Market Value Share (%), by Route of Administration, (2019 & 2030)
FIG. 299 India Topical Drug Delivery Market Value Share (%), by End-user, (2019 & 2030)
FIG. 300 COVID-19 Impact on India Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
FIG. 301 COVID-19 Impact on India Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
FIG. 302 COVID-19 Impact on India Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
FIG. 303 COVID-19 Impact on India Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
FIG. 304 Australia Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 305 Australia Semi-Solid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 306 Australia Liquid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 307 Australia Liquid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 308 Australia Transdermal Products Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 309 Australia Topical Drug Delivery Market Value Share (%), by Route of Administration, (2019 & 2030)
FIG. 310 Australia Topical Drug Delivery Market Value Share (%), by End-User, (2019 & 2030)
FIG. 311 COVID-19 Impact on Australia Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
FIG. 312 COVID-19 Impact on Australia Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
FIG. 313 COVID-19 Impact on Australia Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
FIG. 314 COVID-19 Impact on Australia Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
FIG. 315 Rest of Asia-Pacific Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 316 Rest of APAC Semi-Solids Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 317 Rest of APAC Liquid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 318 Rest of APAC Liquid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 319 Rest of APAC Transdermal Products Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 320 Rest of Asia-Pacific Topical Drug Delivery Market Value Share (%), by Route of Administration, (2019 & 2030)
FIG. 321 Rest of Asia-Pacific Topical Drug Delivery Market Value Share (%), by End-User, (2019 & 2030)
FIG. 322 COVID-19 Impact on Rest of Asia-Pacific Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
FIG. 323 COVID-19 Impact on Rest of Asia-Pacific Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
FIG. 324 COVID-19 Impact on Rest of Asia-Pacific Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
FIG. 325 COVID-19 Impact on Rest of Asia-Pacific Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
FIG. 326 LAMEA Topical Drug Delivery Market (USD Million), 2019-2030
FIG. 327 LAMEA Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 328 LAMEA Semi-Solid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 329 LAMEA Liquid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 330 LAMEA Solid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 331 LAMEA Transdermal Products Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 332 LAMEA Topical Drug Delivery Market Value Share (%), by Route of Administration, (2019 & 2030)
FIG. 333 LAMEA Topical Drug Delivery Market Value Share (%), by End-User, (2019 & 2030)
FIG. 334 LAMEA Topical Drug Delivery Market Value Share (%), by Country, (2019 & 2030)
FIG. 335 COVID-19 Impact on LAMEA Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
FIG. 336 COVID-19 Impact on LAMEA Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
FIG. 337 COVID-19 Impact on LAMEA Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
FIG. 338 COVID-19 Impact on LAMEA Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
FIG. 339 Brazil Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 340 Brazil Semi-Solid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 341 Brazil Liquid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 342 Brazil Solid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 343 Brazil Transdermal Products Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 344 Brazil Topical Drug Delivery Market Value Share (%), by Route of Administration, (2019 & 2030)
FIG. 345 Brazil Topical Drug Delivery Market Value Share (%), by End-User, (2019 & 2030)
FIG. 346 COVID-19 Impact on Brazil Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
FIG. 347 COVID-19 Impact on Brazil Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
FIG. 348 COVID-19 Impact on Brazil Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
FIG. 349 COVID-19 Impact on Brazil Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
FIG. 350 Mexico Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 351 Mexico Semi-Solid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 352 Mexico Liquid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 353 Mexico Solid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 354 Mexico Transdermal Products Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 355 Mexico Topical Drug Delivery Market Value Share (%), by Route of Administration, (2019 & 2030)
FIG. 356 Mexico Topical Drug Delivery Market Value Share (%), by End-User, (2019 & 2030)
FIG. 357 COVID-19 Impact on Mexico Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
FIG. 358 COVID-19 Impact on Mexico Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
FIG. 359 COVID-19 Impact on Mexico Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
FIG. 360 COVID-19 Impact on Mexico Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
FIG. 361 Rest of LAMEA Topical Drug Delivery Market Value Share (%), Product, (2019 & 2030)
FIG. 362 Rest of LAMEA Semi-Solid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 363 Rest of LAMEA Liquid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 364 Rest of LAMEA Solid Formulations Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 365 Rest of LAMEA Transdermal Products Topical Drug Delivery Market Value Share (%), by Product, (2019 & 2030)
FIG. 366 Rest of LAMEA Topical Drug Delivery Market Value Share (%), by Route of Administration, (2019 & 2030)
FIG. 367 Rest of LAMEA Topical Drug Delivery Market Value Share (%), by End-User, (2019 & 2030)
FIG. 368 COVID-19 Impact on Rest of LAMEA Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 1 (V-Shaped Recovery)
FIG. 369 COVID-19 Impact on Rest of LAMEA Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 2 (U-Shaped Recovery)
FIG. 370 COVID-19 Impact on Rest of LAMEA Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 3 (L-Shaped Recovery)
FIG. 371 COVID-19 Impact on Rest of LAMEA Topical Drug Delivery Market (USD Million), 2019-2030: Scenario 4 (W-Shaped Recovery)
FIG. 372 GlaxoSmithKline Sales (USD million)
FIG. 373 Glaxosmithkline Sales (USD million), By Business Segment
FIG. 374 Glaxosmithkline Sales (USD million), By Business
FIG. 375 Glaxosmithkline Sales (USD million), By Geography
FIG. 376 GlaxoSmithKline Sales (USD million) by Geography
FIG. 377 Johnson & Johnson Sales (USD million)
FIG. 378 Johnson & Johnson Sales (USD million), By Business Segment
FIG. 379 Johnson & Johnson Sales (USD million), By Geography
FIG. 380 Bausch Health Companies Sales (USD million) 2015-2019
FIG. 381 Bausch Health Companies Sales (USD million) 2019, By Business Segment
FIG. 382 Bausch Health Companies Sales (USD million) 2019, By Geography
FIG. 383 Merck & Co. Sales (USD million) 2015-2019
FIG. 384 Merck & Co. Sales (USD million) 2019, By Business Segment
FIG. 385 Merck & Co. Sales (USD million) 2019, By Geography
FIG. 386 LEO Pharma A/S Sales (USD million) 2015-2019
FIG. 387 LEO Pharma A/S Sales (USD million) 2019, By Business Segment
FIG. 388 LEO Pharma A/S Sales (USD million) 2019, By Geography
FIG. 389 Hisamitsu Pharmaceutical Co. Inc. Sales (USD million) 2015-2019
FIG. 390 Hisamitsu Pharmaceutical Co. Inc. Sales (USD million) 2019, By Business Segment
FIG. 391 Hisamitsu Pharmaceutical Co. Inc. Sales (USD million) 2019, By Business Segment
FIG. 392 Hisamitsu Pharmaceutical Co. Inc. Sales (USD million) 2019, By Geography
FIG. 393 Novartis AG. Sales (USD million) 2015-2019
FIG. 394 Novartis AG Sales (USD million) 2019, By Business Segment
FIG. 395 Novartis AG Sales (USD million) 2019, By Geography
FIG. 396 Glenmark Pharmaceuticals Sales (USD million) 2015-2019
FIG. 397 Glenmark Pharmaceuticals Sales (USD million) 2019, By Geography
FIG. 398 Cipla Limited Sales (USD million) 2015-2019
FIG. 399 Cipla Limited Sales (USD million) 2019, By Business Segment
FIG. 400 Cipla Limited Sales (USD million) 2019, By Geography
FIG. 401 Mylan N.V. Sales (USD million) 2015-2019
FIG. 402 Mylan N.V. Sales (USD million) 2019, By Business Segment
FIG. 403 Mylan N.V. Sales (USD million) 2019, By Geography
Companies Profiled in the Report
Bausch Health Companies
Cipla Ltd.
Glaxosmithkline
Glenmark Pharmaceuticals
Hisamitsu Pharmaceutical Co. Inc.
Johnson & Johnson
LEO Pharma A/S
Merck & Co.
Mylan N.V.
Novartis AG
List of Other Companies
3M
4P Therapeutics
AbbVie
Abbvie Inc.
Acrux Limited
Actuated Medical, Inc.
Adhex Pharma
Allergan plc
Almirall S.A.
Amgen
Antares Pharma, Inc.
Appco Pharmaceutical Corp
Arecor
Astellas
Atral
AVIZ Laboratories
AVRO Life Science
Basic Pharma
Bayer Ag
Bidu Biotech
Biofarmitalia s.r.l
Biozoc INC
Blaze Remedies
Bliss Gvs Pharma Ltd
Bluewaterresearch
Boehringer Ingelheim
Bristol-Myers Squibb
Cambrex Corporation
Camurus
Carbogen Amcis SAS
Centurion Laboratories Private Limited
Concert Pharmaceuticals
Connote Healthcare
Corium International, Inc.
Cospex Pharmaceuticals Private Limited
Crescita Therapeutics Inc
Crescita TherapeuticsiNC
Delpharm Group
Dolvis Bio Pharma Private Limited
DPT Laboratories, Ltd.
Durect Corporation
Easton Pharmaceuticals Inc.
Eli Lilly and Company
Endo Pharmaceuticals Inc.
Enfucell
Estrellas Life Sciences Private Limited
eurofins
Famar S.A.
Famar S.A.
Farbe Firma
Flagship biotech
Galderma
Galderma Holding SA
Glint Cosmetics Private Limited
Gracure Pharmaceuticals Ltd.
Grunenthal's Tecnandina S.A.
Guru Baba Pharmax Private Limited
Healthkind Labs Pvt. Ltd.
Integrated Laboratories Private Limited
Isis Biopolymer
Janssen Global Services
JGL
Jubilant HollisterStier
Laboratories Chemineau
Laboratories Gilbert
Lancer Therapeutics
Lavipharm
Lead Chemicals Co., Inc.
Lecifarma
Legacy Pharmaceuticals Switzerland
Lexine Technochem Private Limited
Lohmann Therapie-Systeme AG
Lohmann Therapie-Systeme AG
Lupin Ltd
M/S Slash Life Vision
Mayne Pharma
Medherant
Medix Biocare
Medpharm
MEDRx Co. Ltd.
Micropoint Technologies
Mission Pharmacal
Neptune Life Sciences Private Limited
Nestle
Nitto Denko Corp.
Nitto Denko Corporation
Nitto Denko Corporation
Novosis AG
One Pharma S.A.
Panacea Biotec
Pfizer, Inc.
Pharmatek Laboratories
Pharmatis
Pocono Coated Products LLC
Pocono Coated Products LLC
Polpharma
Priyans Drugs
Prometheon Pharma
Prosollus Pharmaceuticals
Puneet Laboratories Private Limited
Purdue Pharma L.P.
Rafarm S.A
Raphas Co. Ltd.
Recipharm
Rezicure Pharmaceuticals
S.C. Rompharm Company SRL
Salvus Pharma
Samyang Biopharmaceuticals Corporation
Saneca Pharmaceuticals
Saphnix Life Science
Sheffield Pharmaceuticals, Inc.
Sienna Biopharmaceuticals
Sirnaomics, Inc
Skinvisible Pharmaceuticals, Inc.
Skinvisible Pharmaceuticals, Inc.
Skylla Pharmaceuticals
Sofarimex
Softigel
SOLVAY S.A
Specpharm
Stellar- Bio Labs
Stiefel Laboratories, Inc.
Sun Pharmaceutical Industries Ltd.
Tapemark
Teikoku Pharma
Teva Pharmaceuticals
The Madras Pharmaceuticals
TheraSolve NV.
Topical Pharmaceuticals Inc.
Transdermal Technologies, Inc.
Trumac Healthcare
UPM Pharmaceuticals
Valeant Pharmaceuticals International, Inc.
Vasa Cosmetics Private Limited
WellSpring Pharmaceutical
Zosano
Zynerba Pharmaceuticals
List of Organizations Mentioned in the Report:
AiM at Melanoma Foundation
American Academy of Dermatology (AAD)
American Burn Association
Australian Institute of Health & Welfare
BrightFocus Foundation
Bureau of Labor Statistics
Canadian Dermatology Association
Cancer Research UK
Emory University School of Medicine
Foreign Direct Investment (FDA)
Georgia Institute of Technology
Global Cancer observatory
Global Psoriasis Atlas
Guttmacher Institute
India Brand Equity Foundation (IBEF)
International Diabetes Federation (IDF)
Journal de Mycologie Medicine
National Health Service
National Institute of allergy and Infectious diseases
Neurological Health Charities Canada (NHCC)
NHSN Surgical Site Infection Surveillance
NIBIB Quantum Grant
Oculus Innovative Science
U.S. Department of Agriculture (USDA)
UN Department of Economic and Social Affairs
World Cancer Research Fund International
World health Organization (WHO)
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
